Your browser doesn't support javascript.
loading
Managing problematic severe asthma: beyond the guidelines.
Pike, Katharine C; Levy, Mark L; Moreiras, John; Fleming, Louise.
Affiliation
  • Pike KC; Respiratory, Critical Care and Anaesthesia Section, UCL Great Ormond Street Institute of Child Health, London, UK.
  • Levy ML; Harrow, Respiratory Lead, Harrow CCG, & Clinical Lead National Review of Asthma Deaths, Harrow, London, UK.
  • Moreiras J; Department of Paediatrics, Whittington Health, London, UK.
  • Fleming L; National Heart and Lung Intitute, Imperial College London, and Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Arch Dis Child ; 103(4): 392-397, 2018 04.
Article in En | MEDLINE | ID: mdl-28903951
This review discusses issues related to managing problematic severe asthma in children and young people. A small minority of children have genuinely severe asthma symptoms which are difficult to control. Children with genuinely severe asthma need investigations and treatments beyond those described within conventional guidelines. However, the majority of children with poor symptom control despite high-intensity treatment achieve improvement in their asthma control once attention has been paid to the basics of asthma management. Basic asthma management requires optimisation of inhaler technique and treatment adherence, avoidance of environmental triggers and self-management education. It is also important that clinicians recognise risk factors that predispose patients to asthma exacerbations and potentially life-threatening attacks. These correctable issues need to be tackled in partnership with children and young people and their families. This requires a coordinated approach between professionals across healthcare settings. Establishing appropriate infrastructure for coordinated asthma care benefits not only those with problematic severe asthma, but also the wider asthma population as similar correctable issues exist for children with asthma of all severities. Investigation and management of genuine severe asthma requires specialist multidisciplinary expertise and a systematic approach to characterising patients' asthma phenotypes and delivering individualised care. While inhaled corticosteroids continue to play a leading role in asthma therapy, new treatments on the horizon might further support phenotype-specific therapy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Severity of Illness Index / Disease Management Type of study: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limits: Adolescent / Child / Humans Language: En Journal: Arch Dis Child Year: 2018 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Severity of Illness Index / Disease Management Type of study: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies Limits: Adolescent / Child / Humans Language: En Journal: Arch Dis Child Year: 2018 Document type: Article Country of publication: United kingdom